Thrombolytic treatment and complement activation

A. Agostoni, M. Gardinali, D. Frangi, M. Cugno, C. Cafaro, L. Conciato, C. Sponzilli, E. Salmoirago

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Details of possible complement activation in acute myocardial infarction (AMI) and the in vivo effects of fibrinolytic agents on this activation are not yet known. We measured complement activation in 40 patients with AMI: 20 were treated with streptokinase, and 20 did not receive any fibrinolytic agent. Anaphylatoxin C4a, C3a and membrane attack complexes SC5b-9 increased about 10-fold (p <0.0001) during streptokinase infusion. These were no increases in complement catabolic products in AMI patients not treated with streptokinase. Significant transient leukopenia (-29.5%, 7.0 SEM, p = 0.001) and a drop in systolic pressure (-29%, 3.4 SEM, p <0.0001) occurred after 15 min of streptokinase infusion simultaneously with the peak of anaphylatoxins in plasma.

Original languageEnglish
Pages (from-to)178-179
Number of pages2
JournalAnnali Italiani di Medicina Interna
Volume9
Issue number3
Publication statusPublished - 1994

Fingerprint

Streptokinase
Complement Activation
Anaphylatoxins
Fibrinolytic Agents
Myocardial Infarction
Complement Membrane Attack Complex
Leukopenia
Therapeutics
Blood Pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Agostoni, A., Gardinali, M., Frangi, D., Cugno, M., Cafaro, C., Conciato, L., ... Salmoirago, E. (1994). Thrombolytic treatment and complement activation. Annali Italiani di Medicina Interna, 9(3), 178-179.

Thrombolytic treatment and complement activation. / Agostoni, A.; Gardinali, M.; Frangi, D.; Cugno, M.; Cafaro, C.; Conciato, L.; Sponzilli, C.; Salmoirago, E.

In: Annali Italiani di Medicina Interna, Vol. 9, No. 3, 1994, p. 178-179.

Research output: Contribution to journalArticle

Agostoni, A, Gardinali, M, Frangi, D, Cugno, M, Cafaro, C, Conciato, L, Sponzilli, C & Salmoirago, E 1994, 'Thrombolytic treatment and complement activation', Annali Italiani di Medicina Interna, vol. 9, no. 3, pp. 178-179.
Agostoni A, Gardinali M, Frangi D, Cugno M, Cafaro C, Conciato L et al. Thrombolytic treatment and complement activation. Annali Italiani di Medicina Interna. 1994;9(3):178-179.
Agostoni, A. ; Gardinali, M. ; Frangi, D. ; Cugno, M. ; Cafaro, C. ; Conciato, L. ; Sponzilli, C. ; Salmoirago, E. / Thrombolytic treatment and complement activation. In: Annali Italiani di Medicina Interna. 1994 ; Vol. 9, No. 3. pp. 178-179.
@article{5717ab88f7d2404bb6bbb317756a34e1,
title = "Thrombolytic treatment and complement activation",
abstract = "Details of possible complement activation in acute myocardial infarction (AMI) and the in vivo effects of fibrinolytic agents on this activation are not yet known. We measured complement activation in 40 patients with AMI: 20 were treated with streptokinase, and 20 did not receive any fibrinolytic agent. Anaphylatoxin C4a, C3a and membrane attack complexes SC5b-9 increased about 10-fold (p <0.0001) during streptokinase infusion. These were no increases in complement catabolic products in AMI patients not treated with streptokinase. Significant transient leukopenia (-29.5{\%}, 7.0 SEM, p = 0.001) and a drop in systolic pressure (-29{\%}, 3.4 SEM, p <0.0001) occurred after 15 min of streptokinase infusion simultaneously with the peak of anaphylatoxins in plasma.",
author = "A. Agostoni and M. Gardinali and D. Frangi and M. Cugno and C. Cafaro and L. Conciato and C. Sponzilli and E. Salmoirago",
year = "1994",
language = "English",
volume = "9",
pages = "178--179",
journal = "Annali Italiani di Medicina Interna",
issn = "0393-9340",
publisher = "CEPI s.r.l.",
number = "3",

}

TY - JOUR

T1 - Thrombolytic treatment and complement activation

AU - Agostoni, A.

AU - Gardinali, M.

AU - Frangi, D.

AU - Cugno, M.

AU - Cafaro, C.

AU - Conciato, L.

AU - Sponzilli, C.

AU - Salmoirago, E.

PY - 1994

Y1 - 1994

N2 - Details of possible complement activation in acute myocardial infarction (AMI) and the in vivo effects of fibrinolytic agents on this activation are not yet known. We measured complement activation in 40 patients with AMI: 20 were treated with streptokinase, and 20 did not receive any fibrinolytic agent. Anaphylatoxin C4a, C3a and membrane attack complexes SC5b-9 increased about 10-fold (p <0.0001) during streptokinase infusion. These were no increases in complement catabolic products in AMI patients not treated with streptokinase. Significant transient leukopenia (-29.5%, 7.0 SEM, p = 0.001) and a drop in systolic pressure (-29%, 3.4 SEM, p <0.0001) occurred after 15 min of streptokinase infusion simultaneously with the peak of anaphylatoxins in plasma.

AB - Details of possible complement activation in acute myocardial infarction (AMI) and the in vivo effects of fibrinolytic agents on this activation are not yet known. We measured complement activation in 40 patients with AMI: 20 were treated with streptokinase, and 20 did not receive any fibrinolytic agent. Anaphylatoxin C4a, C3a and membrane attack complexes SC5b-9 increased about 10-fold (p <0.0001) during streptokinase infusion. These were no increases in complement catabolic products in AMI patients not treated with streptokinase. Significant transient leukopenia (-29.5%, 7.0 SEM, p = 0.001) and a drop in systolic pressure (-29%, 3.4 SEM, p <0.0001) occurred after 15 min of streptokinase infusion simultaneously with the peak of anaphylatoxins in plasma.

UR - http://www.scopus.com/inward/record.url?scp=0027979088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027979088&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 178

EP - 179

JO - Annali Italiani di Medicina Interna

JF - Annali Italiani di Medicina Interna

SN - 0393-9340

IS - 3

ER -